We are currently recruiting for..
£3,000 (if on placebo) or £4,000 (if you receive the study drug)
Healthy participants needed for the study of an experimental new treatment for primary biliary cholangitis (PBC). You must be aged 18 to 65 and have a BMI between 18 and 30. Smokers and vapers are allowed but you can’t smoke or vape while in the ward. It involves 3 nights’ residence on our wards and 5 outpatient visits (if on placebo), plus 1 additional follow-up (if you receive the study drug). Admissions on 13 July 2026.
£2,250 + reasonable travel expenses
People with treatment resistant depression (at least two failed treatments) needed for the study of a potential new medicine for treating the condition. You must be aged 18 to 75 and have been taking sertraline, citalopram or escitalopram, at a stable dose, for at least 6 weeks. You can’t take part if you’ve used any psychedelic substances in the last 6 months. It involves 2 nights’ residence on our wards, and 11 outpatient visits (some of them can be video calls). Study ongoing.
£3,250 (placebo) or £7,130 (if you receive the study drug)
Healthy participants needed for the study of an experimental new medicine for treating age-related macular degeneration. You must be aged 18 to 65. Smokers and vapers are allowed but you can’t smoke or vape while on the ward. You must also have had a vaccination for meningitis and pneumonia. It involves 3 nights’ residence on our wards and 4 outpatient visits (if on placebo), plus 5 additional follow-ups (if you receive the study drug). Admissions on 29 June, 3 August and 7 September 2026.
£4,850 in partial payments
Healthy participants needed for the study of an experimental new medicine for organ damage in acute pancreatitis. You must be aged 18 to 55, with a BMI between 18.5 and 32, weigh at least 50 kg, and not have used nicotine products in the last 6 months. Oral contraceptives are not allowed. It involves 2 screenings (including an echocardiogram), 11 nights’ residence, and 2 outpatient visits. Admissions on 22 June 2026.
£3,750
Healthy men needed for the study of an experimental new medication for the treatment of incomplete response - major depressive disorder (IR-MDD). You must be aged 23 to 55, with BMI 18 to 32, and not have used nicotine products for at least 2 months. It involves up to 4 screenings (including an MRI and an echocardiogram), 3 PET scans, 3 nights’ residence on our ward and 1 follow-up. Participants are expected to experience a psychedelic effect while inside the PET scanner. Admission on 2 June 2026.
Up to £2,380 + reasonable travel expenses
People with Chemotherapy Induced Peripheral Neuropathy (CIPN) needed for the study of a potential new medicine, given as a gel, to treat the condition. You must be aged 18 to 80, have received chemotherapy treatment for cancer and be in remission, and have had CIPN for at least 3 months. It involves up to 6 outpatient visits (including 3 optional skin biopsies) and 1 telephone follow-up. Study ongoing.